| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
Collection of venous blood by venipuncture |
5,967 |
4,759 |
$80K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
465 |
394 |
$60K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
260 |
250 |
$49K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
759 |
729 |
$48K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
124 |
99 |
$44K |
| 80053 |
Comprehensive metabolic panel |
951 |
816 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,264 |
1,057 |
$39K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
424 |
378 |
$31K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
172 |
162 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
186 |
171 |
$13K |
| J3490 |
Unclassified drugs |
701 |
312 |
$12K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22 |
14 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
827 |
483 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
332 |
297 |
$6K |
| 81001 |
|
336 |
250 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
103 |
96 |
$4K |
| 80061 |
Lipid panel |
131 |
123 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
137 |
119 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
50 |
45 |
$3K |
| 87631 |
|
18 |
17 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27 |
26 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
32 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
51 |
$1K |
| 82607 |
|
28 |
27 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
33 |
27 |
$1K |
| 84439 |
|
29 |
24 |
$836.26 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
31 |
25 |
$823.40 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$639.40 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
15 |
$480.58 |
| 85027 |
|
18 |
14 |
$464.82 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
14 |
$386.96 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
105 |
91 |
$367.37 |
| 84550 |
|
13 |
12 |
$244.17 |
| 85014 |
|
18 |
17 |
$202.38 |
| 85018 |
|
18 |
17 |
$202.38 |
| 36416 |
|
13 |
13 |
$121.56 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16 |
12 |
$19.44 |
| A9270 |
Non-covered item or service |
251 |
131 |
$0.00 |